To: twentyfirstcenturyfox who wrote (9033 ) 3/15/2002 6:05:09 AM From: axial Read Replies (1) | Respond to Hi, fox -think these things through , don't have the work ethic to do the research , and don't have the intellectual honesty to consider anything but their own blind, malicious aspersions.real reasons for the difficulties that DMX has encountered.likely effort on the part of competitiors; the question of how much it has succeeded is not "knowable", IMO.the difficulties and delay being encountered by DMX result from the unconventional nature of these drugs. chemical approach, as opposed to an approach with its roots in biology and medicine): misperception.both of these therapeutics are efficacious, and safe.I consider HC to be the Cowardly Cousin to FDA. "...is there not likely to be a built in bias, at FDA, against approving any medication with DMSO in it?" overcome that bias.Based on the information we have now there is little doubt that Pennsaid will be approved by FDA, and subsequently, (we hope) by HC. it is almost a certainty that Pennsaid has overcome the FDA bias against DMSO. Please refer to other posts, especially those that show the flow-chart of FDA approval."Are you aware of DMSO being used as a transdermal carrier for any drug other than in Pennsaids?" is approved, this gives it a tremendous head-start on competitors. I repeat the evidence is that Pennsaid is 99% through the process of approval. "Has any other drug using DMSO been approved by the FDA?" fda.gov acmed.org fda.gov The following two are of interest ;- ) http://www.pharmcast.com/PatentToSubWeb/Classification/Classification1000.htmpharmcast.com ;
